Research

CCP Invasive Service is a leading expert in invasive research. With a 20-year history of participating in invetigational trials, we can offer the most current treatments and technology to patients who suffer from coronary artery disease, peripheral vascular disease and cerebrovascular disease. Research trials that have brought revolutionary changes, such as coated stents, carotid disease stents, abdominal aneurysm treatment, heart attack drug therapy are available to our patients because of our participation in interventional trials. participation in interventional trials.Patients have the advantage of minimally invasive cardiovascular treatment, no general anesthesia, and a shorter discharge and recovery. CCP Invasive is committed to providing our patients with the latest research trials and innovative approaches to their disease.

Currently available research trials are:  DIRECT Direct myocardial revascularization   Laser trial for Class III IV angina  SAFER SVG extraction type catheter  VORTEX For use in saphenous vein bypass interventions  Iliac Stent IVT stent versus conventional treatment for iliac stenosis  A to Z Chest pain patients who receive Aggrastat, Heparin, and ASA.   Can have intervention immediately or Aggrastat must run for at least 12   hours after intervention. Then patients are started on ZOCOR.  Acute 2 Lovenox/TEE/Cardioversion  Madit II AICD post MI with Ef<30%  Target Trial Cath lab study, Double Blind use of Aggrastat and ReoPro  ACS Multi-Link   5-year follow-up on patients who received ACS Multi-Link 3 years ago  AVE GFX Stent   5-year follow-up for AVE GFX stents  SUPORT Boston Scimed stents versus ACS stents  CONSERVE IVT low-pressure stent versus Guidant stent  LP Stent LP versus Guidant stent  HERMES Renal stents  SAPPHIRE High-risk randomized trial CEA vs. Stent with Distal Protection  ARCHER Carotid stents in High Risk PTS Non-randomized  CRUISE Integrilin with Enoxaparin  PRESTO Prevention of Restenosis with Tranilast  SIRIUS Drug-coated Stent to Prevent Restenosis  LIMIT Brachytherapy to Prevent Restenosis  SAPHIRE Carotid Stent with Filter to Prevent Embolization  CREST NIH Sponsored Comparing CEA to Carotid Stent with Distal   Protection � Low-risk patients  VEGAS Evaluation of Angiojet for Saphenouse Vein Graft Disease  LACI Excimer Laser for Critical Limb Ischemia  ARCHER High-risk Non-randomized Carotid Stent with Distal Protection  CARESS Randomized Carotid Stent Trial for Low-risk  DELIVER Randomized Coated Stent Trial to Reduce Restenosis